Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Untargeted Molecular Discovery in Primary Metabolism: Collision Cross Section as a Molecular Descriptor in Ion Mobility-Mass Spectrometry.

Nichols CM, Dodds JN, Rose BS, Picache JA, Morris CB, Codreanu SG, May JC, Sherrod SD, McLean JA.

Anal Chem. 2018 Dec 18;90(24):14484-14492. doi: 10.1021/acs.analchem.8b04322. Epub 2018 Nov 30.

PMID:
30449086
2.

Can the Sum of Adenoma Diameters (Adenoma Bulk) on Index Examination Predict Risk of Metachronous Advanced Neoplasia?

Anderson JC, Morris CB, Robertson DJ, Barry ELR, Figueiredo JC, Cruz-Correa M, Bostick RM, Ahnen DJ, Baron JA.

J Clin Gastroenterol. 2018 Aug;52(7):628-634. doi: 10.1097/MCG.0000000000000899.

PMID:
28767463
3.

Unmetabolized Folic Acid, Tetrahydrofolate, and Colorectal Adenoma Risk.

Rees JR, Morris CB, Peacock JL, Ueland PM, Barry EL, McKeown-Eyssen GE, Figueiredo JC, Snover DC, Baron JA.

Cancer Prev Res (Phila). 2017 Aug;10(8):451-458. doi: 10.1158/1940-6207.CAPR-16-0278. Epub 2017 Jun 9.

4.

Development and validation of the Patient-Physician Relationship Scale among patients with irritable bowel syndrome.

Kurlander JE, Chey WD, Morris CB, Hu YJB, Padival RK, Bangdiwala SI, Norton NJ, Norton WF, Drossman DA.

Neurogastroenterol Motil. 2017 Oct;29(10):1-8. doi: 10.1111/nmo.13106. Epub 2017 May 22.

5.

Ion Mobility Collision Cross Section Compendium.

May JC, Morris CB, McLean JA.

Anal Chem. 2017 Jan 17;89(2):1032-1044. doi: 10.1021/acs.analchem.6b04905. Epub 2016 Dec 28. Review. No abstract available.

6.

Developing and Evaluating a Clinic-Based Decision Aid Delivery System.

Lewis CL, Dalton AF, Drake L, Brenner AT, Colford CM, DeLeon C, McDonald S, Morris CB, Waters M, Werner L, Chung A.

MDM Policy Pract. 2016 Jul 7;1(1):2381468316656850. doi: 10.1177/2381468316656850. eCollection 2016 Jul-Dec.

7.

Validation of a Prediction Tool for Abusive Head Trauma.

Cowley LE, Morris CB, Maguire SA, Farewell DM, Kemp AM.

Pediatrics. 2015 Aug;136(2):290-8. doi: 10.1542/peds.2014-3993.

8.

Smoking-associated risks of conventional adenomas and serrated polyps in the colorectum.

Figueiredo JC, Crockett SD, Snover DC, Morris CB, McKeown-Eyssen G, Sandler RS, Ahnen DJ, Robertson DJ, Burke CA, Bresalier RS, Church JM, Church TR, Baron JA.

Cancer Causes Control. 2015 Mar;26(3):377-86. doi: 10.1007/s10552-014-0513-0. Epub 2014 Dec 24.

9.

Conformational ordering of biomolecules in the gas phase: nitrogen collision cross sections measured on a prototype high resolution drift tube ion mobility-mass spectrometer.

May JC, Goodwin CR, Lareau NM, Leaptrot KL, Morris CB, Kurulugama RT, Mordehai A, Klein C, Barry W, Darland E, Overney G, Imatani K, Stafford GC, Fjeldsted JC, McLean JA.

Anal Chem. 2014 Feb 18;86(4):2107-16. doi: 10.1021/ac4038448. Epub 2014 Feb 4.

10.

The digital rectal examination: a multicenter survey of physicians' and students' perceptions and practice patterns.

Wong RK, Drossman DA, Bharucha AE, Rao SS, Wald A, Morris CB, Oxentenko AS, Ravi K, Van Handel DM, Edwards H, Hu Y, Bangdiwala S.

Am J Gastroenterol. 2012 Aug;107(8):1157-63. doi: 10.1038/ajg.2012.23.

PMID:
22858996
11.

Partner burden in irritable bowel syndrome.

Wong RK, Drossman DA, Weinland SR, Morris CB, Leserman J, Hu Y, Kelapure R, Bangdiwala SI.

Clin Gastroenterol Hepatol. 2013 Feb;11(2):151-5. doi: 10.1016/j.cgh.2012.07.019. Epub 2012 Jul 31.

PMID:
22858730
12.

Diagnosis, characterization, and 3-month outcome after detoxification of 39 patients with narcotic bowel syndrome.

Drossman DA, Morris CB, Edwards H, Wrennall CE, Weinland SR, Aderoju AO, Kulkarni-Kelapure RR, Hu YJ, Dalton C, Bouma MH, Zimmerman J, Rooker C, Leserman J, Bangdiwala SI.

Am J Gastroenterol. 2012 Sep;107(9):1426-40. doi: 10.1038/ajg.2012.142. Epub 2012 Jun 19.

PMID:
22710577
13.

Development and validation of the irritable bowel syndrome satisfaction with care scale.

Dorn SD, Morris CB, Schneck SE, Hopper TM, Hu YJ, Kelapure R, Weinland SR, Norton WF, Norton NJ, Drossman DA.

Clin Gastroenterol Hepatol. 2011 Dec;9(12):1065-71.e1-2. doi: 10.1016/j.cgh.2011.08.009. Epub 2011 Aug 18.

PMID:
21854738
14.

Characterization of episodes of irritable bowel syndrome using ecological momentary assessment.

Weinland SR, Morris CB, Hu Y, Leserman J, Bangdiwala SI, Drossman DA.

Am J Gastroenterol. 2011 Oct;106(10):1813-20. doi: 10.1038/ajg.2011.170. Epub 2011 Jun 7.

PMID:
21647206
15.

Psychosocial factors are more important than disease activity in determining gastrointestinal symptoms and health status in adults at a celiac disease referral center.

Dorn SD, Hernandez L, Minaya MT, Morris CB, Hu Y, Lewis S, Leserman J, Bangdiwala SI, Green PH, Drossman DA.

Dig Dis Sci. 2010 Nov;55(11):3154-63. doi: 10.1007/s10620-010-1342-y. Epub 2010 Jul 30.

PMID:
20668941
16.

Cognitive factors affect treatment response to medical and psychological treatments in functional bowel disorders.

Weinland SR, Morris CB, Dalton C, Hu Y, Whitehead WE, Toner BB, Diamant N, Leserman J, Bangdiwala SI, Drossman DA.

Am J Gastroenterol. 2010 Jun;105(6):1397-406. doi: 10.1038/ajg.2009.748. Epub 2010 Jan 19.

PMID:
20087332
17.

The development and validation of a new coeliac disease quality of life survey (CD-QOL).

Dorn SD, Hernandez L, Minaya MT, Morris CB, Hu Y, Leserman J, Lewis S, Lee A, Bangdiwala SI, Green PH, Drossman DA.

Aliment Pharmacol Ther. 2010 Mar;31(6):666-75. doi: 10.1111/j.1365-2036.2009.04220.x. Epub 2009 Dec 15.

18.

Irritable bowel syndrome subtypes defined by Rome II and Rome III criteria are similar.

Dorn SD, Morris CB, Hu Y, Toner BB, Diamant N, Whitehead WE, Bangdiwala SI, Drossman DA.

J Clin Gastroenterol. 2009 Mar;43(3):214-20. doi: 10.1097/MCG.0b013e31815bd749.

PMID:
19623100
19.

Synthesis of analogs of forodesine HCl, a human purine nucleoside phosphorylase inhibitor-Part I.

Kamath VP, Xue J, Juarez-Brambila JJ, Morris CB, Ganorkar R, Morris PE Jr.

Bioorg Med Chem Lett. 2009 May 15;19(10):2624-6. doi: 10.1016/j.bmcl.2009.04.017. Epub 2009 Apr 9.

PMID:
19386498
20.

International survey of patients with IBS: symptom features and their severity, health status, treatments, and risk taking to achieve clinical benefit.

Drossman DA, Morris CB, Schneck S, Hu YJ, Norton NJ, Norton WF, Weinland SR, Dalton C, Leserman J, Bangdiwala SI.

J Clin Gastroenterol. 2009 Jul;43(6):541-50. doi: 10.1097/MCG.0b013e318189a7f9.

21.

A very low-carbohydrate diet improves symptoms and quality of life in diarrhea-predominant irritable bowel syndrome.

Austin GL, Dalton CB, Hu Y, Morris CB, Hankins J, Weinland SR, Westman EC, Yancy WS Jr, Drossman DA.

Clin Gastroenterol Hepatol. 2009 Jun;7(6):706-708.e1. doi: 10.1016/j.cgh.2009.02.023. Epub 2009 Mar 10.

22.

Not all side effects associated with tricyclic antidepressant therapy are true side effects.

Thiwan S, Drossman DA, Morris CB, Dalton C, Toner BB, Diamant NE, Hu JB, Whitehead WE, Leserman J, Bangdiwala SI.

Clin Gastroenterol Hepatol. 2009 Apr;7(4):446-51. doi: 10.1016/j.cgh.2008.11.014. Epub 2008 Nov 21.

23.

Constipation does not develop following elective hysterectomy: a prospective, controlled study.

Sperber AD, Morris CB, Greemberg L, Bangdiwala SI, Goldstein D, Sheiner E, Rusabrov Y, Hu Y, Katz M, Freud T, Neville A, Drossman DA.

Neurogastroenterol Motil. 2009 Jan;21(1):18-22. doi: 10.1111/j.1365-2982.2008.01186.x.

PMID:
18798795
24.

Development of abdominal pain and IBS following gynecological surgery: a prospective, controlled study.

Sperber AD, Morris CB, Greemberg L, Bangdiwala SI, Goldstein D, Sheiner E, Rusabrov Y, Hu Y, Katz M, Freud T, Neville A, Drossman DA.

Gastroenterology. 2008 Jan;134(1):75-84. doi: 10.1053/j.gastro.2007.10.041. Epub 2007 Oct 26.

PMID:
18166349
25.

Cryopreservation of animal and human cell lines.

Morris CB.

Methods Mol Biol. 2007;368:227-36. Review.

PMID:
18080474
26.

The clean catch technique for urine collection in infants and young children.

Morris CB, Vince JD, Ripa P, Tefuarani N.

Trop Doct. 2007 Apr;37(2):125. No abstract available.

PMID:
17540111
27.

Characterization of health related quality of life (HRQOL) for patients with functional bowel disorder (FBD) and its response to treatment.

Drossman D, Morris CB, Hu Y, Toner BB, Diamant N, Whitehead WE, Dalton CB, Leserman J, Patrick DL, Bangdiwala SI.

Am J Gastroenterol. 2007 Jul;102(7):1442-53. Epub 2007 May 17.

PMID:
17509027
28.

Erythropoietin, a hypoxia-regulated factor, elicits a pro-angiogenic program in human mesenchymal stem cells.

Zwezdaryk KJ, Coffelt SB, Figueroa YG, Liu J, Phinney DG, LaMarca HL, Florez L, Morris CB, Hoyle GW, Scandurro AB.

Exp Hematol. 2007 Apr;35(4):640-52. Erratum in: Exp Hematol. 2007 Jul;35(7):1153-61.

PMID:
17379074
29.

Integrin-linked kinase: a hypoxia-induced anti-apoptotic factor exploited by cancer cells.

Abboud ER, Coffelt SB, Figueroa YG, Zwezdaryk KJ, Nelson AB, Sullivan DE, Morris CB, Tang Y, Beckman BS, Scandurro AB.

Int J Oncol. 2007 Jan;30(1):113-22.

PMID:
17143519
30.

A survey on patient educational needs in irritable bowel syndrome and attitudes toward participation in clinical research.

Halpert AD, Thomas AC, Hu Y, Morris CB, Bangdiwala SI, Drossman DA.

J Clin Gastroenterol. 2006 Jan;40(1):37-43.

PMID:
16340632
31.

A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternator.

Drossman DA, Morris CB, Hu Y, Toner BB, Diamant N, Leserman J, Shetzline M, Dalton C, Bangdiwala SI.

Gastroenterology. 2005 Mar;128(3):580-9.

PMID:
15765393
32.

Clinical response to tricyclic antidepressants in functional bowel disorders is not related to dosage.

Halpert A, Dalton CB, Diamant NE, Toner BB, Hu Y, Morris CB, Bangdiwala SI, Whitehead WE, Drossman DA.

Am J Gastroenterol. 2005 Mar;100(3):664-71.

PMID:
15743366
33.

Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders.

Drossman DA, Toner BB, Whitehead WE, Diamant NE, Dalton CB, Duncan S, Emmott S, Proffitt V, Akman D, Frusciante K, Le T, Meyer K, Bradshaw B, Mikula K, Morris CB, Blackman CJ, Hu Y, Jia H, Li JZ, Koch GG, Bangdiwala SI.

Gastroenterology. 2003 Jul;125(1):19-31.

PMID:
12851867
34.

Construction and characterization of an intracellular single-chain human antibody to hepatitis C virus non-structural 3 protein.

Sullivan DE, Mondelli MU, Curiel DT, Krasnykh V, Mikheeva G, Gaglio P, Morris CB, Dash S, Gerber MA.

J Hepatol. 2002 Nov;37(5):660-8.

PMID:
12399234
35.

Identification of a peptide capable of inducing an HIV-1 Tat-specific CTL response.

Morris CB, Thanawastien A, Sullivan DE, Clements JD.

Vaccine. 2001 Oct 12;20(1-2):12-5.

PMID:
11567739
36.

Effectiveness of intranasal immunization with HIV-gp160 and an HIV-1 env CTL epitope peptide (E7) in combination with the mucosal adjuvant LT(R192G).

Morris CB, Cheng E, Thanawastien A, Cárdenas-Freytag L, Clements JD.

Vaccine. 2000 Mar 17;18(18):1944-51.

PMID:
10699345
38.

Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of basic fibroblast growth factor and the alpha v beta 3 integrin.

Barillari G, Sgadari C, Palladino C, Gendelman R, Caputo A, Morris CB, Nair BC, Markham P, Nel A, Stürzl M, Ensoli B.

J Immunol. 1999 Aug 15;163(4):1929-35.

39.

Activation of Bcl-2 promoter-directed gene expression by the human immunodeficiency virus type-1 Tat protein.

Wang Z, Morris GF, Reed JC, Kelly GD, Morris CB.

Virology. 1999 May 10;257(2):502-10.

40.

Lung-specific expression in mice of a dominant negative mutant form of the p53 tumor suppressor protein.

Morris GF, Hoyle GW, Athas GB, Lei WH, Xu J, Morris CB, Friedman M.

J La State Med Soc. 1998 Apr;150(4):179-85.

PMID:
9610073
41.
42.

Does benzene cause multiple myeloma? An analysis of the published case-control literature.

Bezabeh S, Engel A, Morris CB, Lamm SH.

Environ Health Perspect. 1996 Dec;104 Suppl 6:1393-8. Review.

43.

Cervical neoplasia. Pathogenesis, diagnosis, and management.

Robinson WR, Morris CB.

Hematol Oncol Clin North Am. 1996 Oct;10(5):1163-76. Review.

PMID:
8880203
44.

Wild-type and transactivation-defective mutants of human immunodeficiency virus type 1 Tat protein bind human TATA-binding protein in vitro.

Wang Z, Morris GF, Rice AP, Xiong W, Morris CB.

J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Jun 1;12(2):128-38.

PMID:
8680883
45.

Immunihistochemical detection of Bcl-2 in AIDS-associated and classical Kaposi's sarcoma.

Morris CB, Gendelman R, Marrogi AJ, Lu M, Lockyer JM, Alperin-Lea W, Ensoli B.

Am J Pathol. 1996 Apr;148(4):1055-63.

46.
47.

Cryopreservation of animal and human cell lines.

Morris CB.

Methods Mol Biol. 1995;38:179-87. No abstract available.

PMID:
7647856
48.

Large-scale production and storage of monoclonal antibodies and hybridomas.

Clark SA, Griffiths JB, Morris CB.

Methods Mol Biol. 1990;5:631-45. doi: 10.1385/0-89603-150-0:631.

PMID:
21374161
49.

Animal cell culture collections and the supply of authenticated cultures and services for industry and research.

Doyle A, Morris CB, Melling JM.

Biotechnol Genet Eng Rev. 1989;7:259-80. Review. No abstract available.

PMID:
2696474
50.

Temporal order identification for tone/noise stimuli with onset transitions.

Pastore RE, Layer JK, Morris CB, Logan RJ.

Percept Psychophys. 1988 Sep;44(3):257-71. No abstract available.

PMID:
3174357

Supplemental Content

Loading ...
Support Center